FDA Suggests Legislation To Streamline Enforcement In Supplement Market

 
• By Eileen Francis and Malcolm Spicer

Congress should consider legislation authorizing agency to conduct enforcement more directly, says Associate Commissioner Schiller. In FDLI conference keynote, he discussed compliance with FDA regulations across markets it regulates, but made specific example of saying FDA is comparatively hamstrung in regulating businesses marketing products labeled as supplements.

RulesRegulationsBooks_1200x675

The Food and Drug Administration needs authority to regulate dietary supplement manufacturing and marketing more directly and efficiently, says FDA Principal Associate Commissioner Lowell Schiller.

Congress should consider legislation that would authorize the agency with regulatory oversight that eliminates space "for potential bad actors to put the public at risk," Schiller said at a

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation